Ergoteles LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,723,961
+130.4%
42,389
+174.5%
0.08%
+186.2%
Q1 2023$748,107
-53.7%
15,444
-63.5%
0.03%
-50.8%
Q4 2022$1,616,232
+1.3%
42,343
+33.3%
0.06%
+5.4%
Q3 2022$1,595,000
+60.3%
31,771
+27.9%
0.06%
+86.7%
Q2 2022$995,000
+35.7%
24,841
+26.5%
0.03%
+7.1%
Q1 2022$733,000
-37.1%
19,640
-32.9%
0.03%
-37.8%
Q4 2021$1,165,00029,2600.04%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 160,372$7,594,0006.15%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 408,000$19,319,0005.11%
RTW INVESTMENTS, LP 5,293,966$250,669,0003.91%
GEORGE KAISER FAMILY FOUNDATION 72,105$9,925,0002.07%
SECTORAL ASSET MANAGEMENT INC 504,928$23,908,0001.81%
Redwood Investments, LLC 385,014$18,230,0001.60%
ARMISTICE CAPITAL, LLC 1,396,000$66,101,0001.52%
Integral Health Asset Management, LLC 100,100$4,740,0001.35%
Sofinnova Investments, Inc. 466,840$22,105,0001.33%
Chubb Ltd 8,180$387,0001.10%
View complete list of PTC THERAPEUTICS INC shareholders